The vision care plan industry's vertical monopoly

The attorney for the Union of American Eye Care Providers discusses how vision care plans may be hurting both patients and practitioners. » Read the guest editorial

B+L announce successful Phase 3 study results of new ophthalmic gel

Laval, Canada—Bausch + Lomb recently announced the successful results for its next generation sub-micron gel formulation of loteprednol etabonate in the first Phase 3 study. » More on the study

Moxifloxacin, ciprofloxacin connected to uveitis risk

Vancouver, Canada—A recent study found that current use of moxifloxacin or ciprofloxacin appears to increase the risk for uveitis. » Find out more

Most fluoroquinolones use not connected with glaucoma risk

British Colombia, Canada—A recent study found that there was no detected increase in glaucoma risk with current, recent, or past use of systemic fluoroquinolones, but did find a minimal statistically significant increased risk with distant use. » Find out more